{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:12:30Z","timestamp":1788862350587,"version":"build-2803163510"},"reference-count":168,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ncl.2019.12.001","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T03:04:32Z","timestamp":1580958272000},"page":"231-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Rating Scales and Quantitative Assessments of Movement Disorders"],"prefix":"10.1016","volume":"38","author":[{"given":"Arjun","family":"Tarakad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2019.12.001_bib1","volume":"vol. 2","author":"Fahn","year":"1987"},{"issue":"15","key":"10.1016\/j.ncl.2019.12.001_bib2","first-page":"2129","article-title":"Movement disorder society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib3","first-page":"758","article-title":"Test-retest reliability of the Unified Parkinson\u2019s Disease Rating Scale in patients with early Parkinson\u2019s disease: Results from a multicenter clinical trial","volume":"17","author":"Siderowf","year":"2002","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib4","first-page":"89","article-title":"Interrater reliability of the unified Parkinson\u2019s disease rating scale motor examination","volume":"9","author":"Richards","year":"1994","journal-title":"MovDisord"},{"key":"10.1016\/j.ncl.2019.12.001_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/467131","article-title":"Minimal clinically important difference in Parkinson\u2019s disease as assessed in pivotal trials of pramipexole extended release","volume":"2014","author":"Hauser","year":"2014","journal-title":"Parkinsons Dis"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib6","first-page":"738","article-title":"The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): Status and recommendations","volume":"18","year":"2003","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib7","first-page":"41","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib8","first-page":"228","article-title":"Expanded and independent validation of the Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS)","volume":"260","author":"Martinez-Martin","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib9","first-page":"200","article-title":"Official Japanese Version of the International Parkinson and Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale: Validation Against the Original English Version","volume":"1","author":"Kashihara","year":"2014","journal-title":"MovDisordClinPract"},{"key":"10.1016\/j.ncl.2019.12.001_bib10","first-page":"7","article-title":"Validation of the Hebrew version of the Movement Disorder Society\u2014Unified Parkinson\u2019s Disease Rating Scale","volume":"45","author":"Zitser","year":"2017","journal-title":"ParkinsonismRelatDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib11","first-page":"54","article-title":"Turkish Standardization of Movement Disorders Society Unified Parkinson\u2019s Disease Rating Scale and Unified Dyskinesia Rating Scale","volume":"5","author":"Akbostanci","year":"2018","journal-title":"MovDisordClinPract"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib12","first-page":"97","article-title":"IPMDS-sponsored scale translation program: process, format, and clinimetric testing plan for the MDS-UPDRS and UDysRS","volume":"1","author":"Goetz","year":"2014","journal-title":"MovDisordClinPract"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib13","first-page":"1421","article-title":"Minimal clinically important difference on the Motor Examination part of MDS-UPDRS","volume":"21","author":"Horv\u00e1th","year":"2015","journal-title":"ParkinsonismRelatDisord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ene.13529","article-title":"The Parkinson\u2019s Disease Composite Scale: results of the first validation study","volume":"25","author":"Stocchi","year":"2018","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/ene.13976","article-title":"Extensive validation study of the Parkinson\u2019s Disease Composite Scale","volume":"26","author":"Martinez-Martin","year":"2019","journal-title":"Eur J Neurol"},{"issue":"16","key":"10.1016\/j.ncl.2019.12.001_bib16","first-page":"2398","article-title":"The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile","volume":"23","author":"Goetz","year":"2008","journal-title":"MovDisord"},{"issue":"14","key":"10.1016\/j.ncl.2019.12.001_bib17","first-page":"2556","article-title":"Temporal stability of the Unified Dyskinesia Rating Scale","volume":"26","author":"Goetz","year":"2011","journal-title":"MovDisord"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.001_bib18","first-page":"1131","article-title":"Task force report on scales to assess dyskinesia in Parkinson\u2019s disease: Critique and recommendations","volume":"25","author":"Colosimo","year":"2010","journal-title":"MovDisord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib19","first-page":"213","article-title":"Independent Spanish Validation of the Unified Dyskinesia Rating Scale","volume":"1","author":"Cubo","year":"2014","journal-title":"MovDisordClinPract"},{"key":"10.1016\/j.ncl.2019.12.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/674796","article-title":"Validation of the Official Slovak Version of the Unified Dyskinesia Rating Scale (UDysRS)","volume":"2015","author":"Skorvanek","year":"2015","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.ncl.2019.12.001_bib21","first-page":"79","article-title":"Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale","volume":"58","author":"Makkos","year":"2019","journal-title":"ParkinsonismRelatDisord"},{"issue":"S1","key":"10.1016\/j.ncl.2019.12.001_bib22","first-page":"S10","article-title":"PDQ-39: a review of the development, validation and application of a Parkinson\u2019s disease quality of life questionnaire and its associated measures","volume":"245","author":"Peto","year":"1998","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib23","first-page":"345","article-title":"Quality of life and Parkinson\u2019s disease: translation and validation of the US Parkinson\u2019s Disease Questionnaire (PDQ-39)","volume":"8","author":"Bushnell","year":"1999","journal-title":"QualLife Res"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib24","first-page":"71","article-title":"Validation of the Japanese version of the Parkinson\u2019s Disease Questionnaire","volume":"43","author":"Kohmoto","year":"2003","journal-title":"RinshoShinkeigaku"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib25","first-page":"565","article-title":"Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson\u2019s Disease Questionnaire (PDQ-39)","volume":"14","author":"Ma","year":"2005","journal-title":"QualLife Res"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10072-018-3524-x","article-title":"Quality of life in Parkinson\u2019s disease: Italian validation of the Parkinson\u2019s Disease Questionnaire (PDQ-39-IT)","volume":"39","author":"Galeoto","year":"2018","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.20344\/amp.8202","article-title":"Reliability and Validity of 39-Item Parkinson\u2019s Disease Questionnaire and Parkinson\u2019s Disease Quality of Life Questionnaire","volume":"30","author":"Jesus-Ribeiro","year":"2017","journal-title":"Acta Med Port"},{"key":"10.1016\/j.ncl.2019.12.001_bib28","first-page":"156","article-title":"Quality of life and Parkinson\u2019s disease: Philippine translation and validation of the Parkinson\u2019s disease questionnaire","volume":"54","author":"Suratos","year":"2018","journal-title":"J\u00a0ClinNeurosci"},{"key":"10.1016\/j.ncl.2019.12.001_bib29","first-page":"83","article-title":"Relationship between the MDS-UPDRS and quality of life: a large multicenter study of 3206 patients","volume":"52","author":"Skorvanek","year":"2018","journal-title":"ParkinsonismRelatDisord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.001_bib31","first-page":"1020","article-title":"Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"MovDisord"},{"key":"10.1016\/j.ncl.2019.12.001_bib32","first-page":"216","article-title":"Depression rating scales in Parkinson\u2019s disease: A critical review updating recent literature","volume":"184","author":"Torbey","year":"2015","journal-title":"J\u00a0AffectDisord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib33","first-page":"668","article-title":"Reliability and validity of the Beck depression inventory in patients with Parkinson\u2019s disease","volume":"21","author":"Visser","year":"2006","journal-title":"MovDisord"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib34","first-page":"1077","article-title":"Depression rating scales in Parkinson\u2019s disease: Critique and recommendations","volume":"22","author":"Schrag","year":"2007","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000002898","article-title":"Detecting depression in Parkinson disease: A systematic review and meta-analysis","volume":"87","author":"Goodarzi","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib36","first-page":"1662","article-title":"Does the Geriatric Depression Scale measure depression in Parkinson\u2019s disease?","volume":"33","author":"Lopez","year":"2018","journal-title":"Int J GeriatrPsychiatry"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib37","first-page":"142","article-title":"Factor analysis of thehamilton depression rating scale in Parkinson\u2019s disease","volume":"21","author":"Broen","year":"2015","journal-title":"ParkinsonismRelatDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib39","first-page":"115","article-title":"Diagnostic validity and factor analysis of montgomery-asberg depression rating scale in parkinson disease population","volume":"29","author":"Ketharanathan","year":"2016","journal-title":"J\u00a0GeriatrPsychiatry Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib40","first-page":"74","article-title":"The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson\u2019s Disease","volume":"15","author":"Leentjens","year":"2003","journal-title":"J\u00a0NeuropsychiatryClinNeurosci"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10072-007-0834-9","article-title":"Evaluation of anxiety in Parkinson\u2019s disease with some commonly used rating scales","volume":"28","author":"Mondolo","year":"2007","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib42","first-page":"407","article-title":"Anxiety rating scales in Parkinson\u2019s disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale","volume":"26","author":"Leentjens","year":"2011","journal-title":"MovDisord"},{"issue":"14","key":"10.1016\/j.ncl.2019.12.001_bib43","first-page":"2015","article-title":"Anxiety rating scales in Parkinson\u2019s disease: critique and recommendations","volume":"23","author":"Leentjens","year":"2008","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib44","first-page":"495","article-title":"Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson\u2019s disease","volume":"68","author":"Kummer","year":"2010","journal-title":"ArqNeuropsiquiatr"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib45","first-page":"34","article-title":"Screening for anxiety symptoms in Parkinson Disease","volume":"26","author":"Stefanova","year":"2013","journal-title":"J\u00a0GeriatrPsychiatry Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/ene.12160","article-title":"Designing a new scale to measure anxiety symptoms in Parkinson\u2019s disease: item selection based on canonical correlation analysis","volume":"20","author":"Martinez-Martin","year":"2013","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib47","first-page":"1035","article-title":"The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale","volume":"29","author":"Leentjens","year":"2014","journal-title":"MovDisord"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib48","first-page":"1777","article-title":"Anxiety rating scales in Parkinson\u2019s disease: a critical review updating recent literature","volume":"27","author":"Dissanayaka","year":"2015","journal-title":"IntPsychogeriatr"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib49","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1212\/WNL.0000000000004771","article-title":"Detecting anxiety in individuals with Parkinson disease: A systematic review","volume":"90","author":"Mele","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib50","first-page":"1461","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"MovDisord"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib51","first-page":"791","article-title":"Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: Critique and recommendations","volume":"34","author":"Evans","year":"2019","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib52","first-page":"242","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s Disease\u2013rating scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib53","first-page":"61","article-title":"A\u00a0short psychosocial questionnaire for patients with Parkinson\u2019s disease: the SCOPA-PS","volume":"56","author":"Marinus","year":"2003","journal-title":"J\u00a0ClinEpidemiol"},{"issue":"15","key":"10.1016\/j.ncl.2019.12.001_bib54","first-page":"2221","article-title":"Assessment of psychiatric complications in Parkinson\u2019s disease: The SCOPA-PC","volume":"22","author":"Visser","year":"2007","journal-title":"MovDisord"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib55","first-page":"674","article-title":"The SCOPA\u2013motor scale for assessment of Parkinson\u2019s disease is a consistent and valid measure","volume":"58","author":"Mart\u00ednez-Mart\u00edn","year":"2005","journal-title":"J\u00a0ClinEpidemiol"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib56","first-page":"1182","article-title":"Cognitive impairment in Parkinson\u2019s disease","volume":"78","author":"Verbaan","year":"2007","journal-title":"J\u00a0NeurolNeurosurgPsychiatry"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/sleep\/26.8.1049","article-title":"Assessment of sleep and sleepiness in Parkinson Disease","volume":"26","author":"Marinus","year":"2003","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib58","first-page":"1306","article-title":"Assessment of autonomic dysfunction in Parkinson\u2019s disease: The SCOPA-AUT","volume":"19","author":"Visser","year":"2004","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib59","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1468-1331.2009.02788.x","article-title":"Independent validation of the scales for outcomes in Parkinson\u2019s disease-autonomic (SCOPA-AUT)","volume":"17","author":"Rodriguez-Blazquez","year":"2010","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-1331.2009.02835.x","article-title":"Assessing autonomic symptoms of Parkinson\u2019s disease with the SCOPA-AUT: a new perspective from Rasch analysis","volume":"17","author":"Forjaz","year":"2010","journal-title":"Eur J Neurol"},{"issue":"13","key":"10.1016\/j.ncl.2019.12.001_bib61","first-page":"1901","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: Results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"MovDisord"},{"issue":"19","key":"10.1016\/j.ncl.2019.12.001_bib62","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1212\/WNL.0b013e3181c0d416","article-title":"International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease","volume":"73","author":"Martinez-Martin","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib63","first-page":"1043","article-title":"The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson\u2019s disease","volume":"23","author":"Gill","year":"2008","journal-title":"MovDisord"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib64","first-page":"1497","article-title":"A\u00a0pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson\u2019s disease in China","volume":"19","author":"Nie","year":"2012","journal-title":"J\u00a0ClinNeurosci"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib65","first-page":"333","article-title":"Validation of the Turkish version of the montreal cognitive assessment scale (MoCA-TR) in patients With Parkinson\u2019s Disease","volume":"28","author":"Ozdilek","year":"2014","journal-title":"ClinNeuropsychol"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib66","first-page":"208","article-title":"Global scales for cognitive screening in Parkinson\u2019s disease: Critique and recommendations","volume":"33","author":"Skorvanek","year":"2018","journal-title":"MovDisord"},{"issue":"4-6","key":"10.1016\/j.ncl.2019.12.001_bib67","first-page":"1","article-title":"Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson\u2019s Disease","volume":"47","author":"Faust-Socher","year":"2019","journal-title":"DementGeriatrCognDisord"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.001_bib68","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/01.WNL.0000091864.39702.1C","article-title":"Assessment of cognition in Parkinson\u2019s disease","volume":"61","author":"Marinus","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib69","first-page":"998","article-title":"Parkinson\u2019s disease-cognitive rating scale: a new cognitive scale specific for Parkinson\u2019s disease","volume":"23","author":"Pagonabarraga","year":"2008","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib70","first-page":"51","article-title":"Validation of the Parkinson\u2019s Disease-cognitive rating scale applying the movement disorder society task force criteria for dementia associated with Parkinson\u2019s Disease","volume":"4","author":"Serrano-Due\u00f1as","year":"2017","journal-title":"MovDisordClinPract"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.33588\/rn.4908.2009254","article-title":"Psychometric attributes of the Parkinson\u2019s Disease-Cognitive Rating Scale. An independent validation study","volume":"49","author":"Mart\u00ednez-Mart\u00edn","year":"2009","journal-title":"Rev Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib72","first-page":"1376","article-title":"Parkinson\u2019s disease-cognitive rating scale: Psychometrics for mild cognitive impairment","volume":"28","author":"Fern\u00e1ndez de Bobadilla","year":"2013","journal-title":"MovDisord"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib73","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A\u00a0new method for measuring daytime sleepiness: the epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"16","key":"10.1016\/j.ncl.2019.12.001_bib74","first-page":"2704","article-title":"Scales to assess sleep impairment in Parkinson\u2019s disease: Critique and recommendations","volume":"25","author":"H\u00f6gl","year":"2010","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.sleep.2013.12.015","article-title":"Criterion validity of the Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale for the diagnosis of sleep disorders","volume":"15","author":"Nishiyama","year":"2014","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib76","first-page":"629","article-title":"The Parkinson\u2019s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson\u2019s disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J\u00a0NeurolNeurosurgPsychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib77","first-page":"317","article-title":"Clinical usefulness of the Parkinson\u2019s disease sleep scale","volume":"11","author":"Tse","year":"2005","journal-title":"ParkinsonismRelatDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib78","first-page":"644","article-title":"Parkinson\u2019s disease sleep scale-validation of the revised version PDSS-2","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib79","first-page":"49","article-title":"The Parkinson fatigue scale","volume":"11","author":"Brown","year":"2005","journal-title":"ParkinsonismRelatDisord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib80","first-page":"737","article-title":"Fatigue in Parkinson\u2019s disease: measurement properties of a generic and a condition-specific rating scale","volume":"46","author":"Nilsson","year":"2013","journal-title":"J\u00a0PainSymptomManage"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib81","first-page":"805","article-title":"Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson\u2019s disease","volume":"25","author":"Friedman","year":"2010","journal-title":"MovDisord"},{"key":"10.1016\/j.ncl.2019.12.001_bib82","first-page":"141","article-title":"Validation study of the Parkinson\u2019s Fatigue Scale in advanced Parkinson\u2019s disease","volume":"10","author":"Martinez-Martin","year":"2019","journal-title":"PatientRelatOutcome Meas"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib83","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib84","first-page":"420","article-title":"Measuring fatigue in Parkinson\u2019s disease: a psychometric study of two brief generic fatigue questionnaires","volume":"32","author":"Hagell","year":"2006","journal-title":"J\u00a0PainSymptomManage"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J\u00a0Psychosom Res"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib86","first-page":"532","article-title":"Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson\u2019s disease","volume":"18","author":"Elbers","year":"2012","journal-title":"ParkinsonismRelatDisord"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib87","first-page":"1623","article-title":"King\u2019s Parkinson\u2019s disease pain scale, the first scale for pain in PD: An international validation","volume":"30","author":"Chaudhuri","year":"2015","journal-title":"MovDisord"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/ene.13691","article-title":"First comprehensive tool for screening pain in Parkinson\u2019s disease: the King\u2019s Parkinson\u2019s Disease Pain Questionnaire","volume":"25","author":"Martinez-Martin","year":"2018","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib89","first-page":"833","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor","volume":"22","author":"Stacy","year":"2007","journal-title":"MovDisord"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib90","first-page":"1567","article-title":"Reliability of a new scale for essential tremor","volume":"27","author":"Elble","year":"2012","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib91","first-page":"60","article-title":"Comparison of the Fahn-Tolosa-Marin clinical rating scale and the essential tremor rating assessment scale","volume":"5","author":"Ondo","year":"2018","journal-title":"MovDisordClinPract"},{"issue":"13","key":"10.1016\/j.ncl.2019.12.001_bib92","first-page":"1793","article-title":"Task force report: Scales for screening and evaluating tremor: Critique and recommendations","volume":"28","author":"Elble","year":"2013","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib93","first-page":"555","article-title":"Alcohol challenge and sensitivity to change of the essential tremor rating assessment scale","volume":"29","author":"Voller","year":"2014","journal-title":"MovDisord"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib94","first-page":"868","article-title":"Assessing tremor severity","volume":"56","author":"Bain","year":"1993","journal-title":"J\u00a0NeurolNeurosurgPsychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib95","first-page":"412","article-title":"The Glass scale: A simple tool to determine severity in essential tremor","volume":"16","author":"Gironell","year":"2010","journal-title":"ParkinsonismRelatDisord"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib96","first-page":"367","article-title":"Quality of life in Essential Tremor Questionnaire (QUEST): Development and initial validation","volume":"11","author":"Tr\u00f6ster","year":"2005","journal-title":"ParkinsonismRelatDisord"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib97","first-page":"767","article-title":"Most of the Quality of Life in Essential Tremor Questionnaire (QUEST) psychometric properties resulted in satisfactory values","volume":"63","author":"Mart\u00ednez-Mart\u00edn","year":"2010","journal-title":"J\u00a0ClinEpidemiol"},{"issue":"5\u20136","key":"10.1016\/j.ncl.2019.12.001_bib98","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18071\/isz.70.0193","article-title":"Independent validation of the Quality of Life in Essential Tremor Questionnaire (QUEST)","volume":"70","author":"Kov\u00e1cs","year":"2017","journal-title":"IdeggyogySz"},{"issue":"9\u201310","key":"10.1016\/j.ncl.2019.12.001_bib99","doi-asserted-by":"crossref","first-page":"310","DOI":"10.18071\/isz.68.0310","article-title":"Turkish version quality of life in essential tremor questionnaire (quest): validity and reliability study","volume":"68","author":"G\u00fcler","year":"2015","journal-title":"IdeggyogySz"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib100","first-page":"661","article-title":"Development of an essential tremor embarrassment assessment","volume":"16","author":"Traub","year":"2010","journal-title":"ParkinsonismRelatDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib102","first-page":"44","article-title":"An evaluation of rating scales utilized for deep brain stimulation for dystonia","volume":"257","author":"Susatia","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib103","first-page":"303","article-title":"Rating scales for dystonia: A multicenter assessment","volume":"18","author":"Comella","year":"2003","journal-title":"MovDisord"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib104","first-page":"874","article-title":"Dystonia rating scales: Critique and recommendations","volume":"28","author":"Albanese","year":"2013","journal-title":"MovDisord"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.001_bib105","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/01.WNL.0000142962.11881.26","article-title":"Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58)","volume":"63","author":"Cano","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.12.001_bib106","first-page":"94","article-title":"Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale","volume":"52","author":"Espay","year":"2018","journal-title":"ParkinsonismRelatDisord"},{"issue":"14 Supplement","key":"10.1016\/j.ncl.2019.12.001_bib107","doi-asserted-by":"crossref","first-page":"S15.001","DOI":"10.1212\/WNL.84.14_supplement.S15.001","article-title":"Reliability of the severity subscale of the revised toronto spasmodic torticollis rating scale (TWSTRS-2) (S15.001)","volume":"84","author":"Comella","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib108","first-page":"563","article-title":"Clinimetric testing of the comprehensive cervical dystonia rating scale","volume":"31","author":"Comella","year":"2016","journal-title":"MovDisord"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib109","first-page":"1521","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"MovDisord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib110","first-page":"407","article-title":"Relationship between various clinical outcome assessments in patients with blepharospasm","volume":"24","author":"Jankovic","year":"2009","journal-title":"MovDisord"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib111","first-page":"925","article-title":"Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm","volume":"118","author":"Wabbels","year":"2011","journal-title":"J\u00a0NeuralTransm"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib112","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.12.001_bib113","first-page":"S75","article-title":"The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies","volume":"46","author":"Roth","year":"2018","journal-title":"ParkinsonismRelatDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib114","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J\u00a0Am Acad Child AdolescPsychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1040-3590.17.4.486","article-title":"Reliability and validity of the Yale Global Tic Severity Scale","volume":"17","author":"Storch","year":"2005","journal-title":"Psychol Assess"},{"issue":"19","key":"10.1016\/j.ncl.2019.12.001_bib116","doi-asserted-by":"crossref","first-page":"e1711","DOI":"10.1212\/WNL.0000000000005474","article-title":"A\u00a0multicenter examination and strategic revisions of the Yale Global Tic Severity Scale","volume":"90","author":"McGuire","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib117","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/cap.2010.0149","article-title":"Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale","volume":"21","author":"Storch","year":"2011","journal-title":"J\u00a0Child AdolescPsychopharmacol"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib118","first-page":"467","article-title":"Systematic review of severity scales and screening instruments for tics: critique and recommendations","volume":"32","author":"Martino","year":"2017","journal-title":"MovDisord"},{"key":"10.1016\/j.ncl.2019.12.001_bib119","series-title":"Tourette\u2019s syndrome and tic disorders: clinical understanding and treatment","year":"1988"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004583-199205000-00013","article-title":"The validity of instruments measuring tic severity in Tourette\u2019s syndrome","volume":"31","author":"Walkup","year":"1992","journal-title":"J\u00a0Am Acad Child AdolescPsychiatry"},{"key":"10.1016\/j.ncl.2019.12.001_bib121","series-title":"Gilles de la Tourette syndrome","first-page":"xxiv","author":"Shapiro","year":"1988"},{"issue":"18","key":"10.1016\/j.ncl.2019.12.001_bib122","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/01.wnl.0000327890.02893.61","article-title":"The Gilles de la Tourette Syndrome-quality of life scale (GTS-QOL): development and validation","volume":"71","author":"Cavanna","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib123","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1155\/2013\/140210","article-title":"The Gilles de la Tourette Syndrome-quality of life scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version","volume":"27","author":"Cavanna","year":"2013","journal-title":"Behav Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib124","first-page":"136","article-title":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib125","first-page":"111","article-title":"Rating scales for motor symptoms and signs in huntington\u2019s disease: critique and recommendations","volume":"5","author":"Mestre","year":"2018","journal-title":"MovDisordClinPract"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib126","first-page":"915","article-title":"Unified Huntington\u2019s disease rating scale: a follow up","volume":"13","author":"Siesling","year":"1998","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib127","first-page":"229","article-title":"A\u00a0shortened version of the motor section of the Unified Huntington\u2019s disease rating scale","volume":"12","author":"Siesling","year":"1997","journal-title":"MovDisord"},{"issue":"14","key":"10.1016\/j.ncl.2019.12.001_bib128","first-page":"1995","article-title":"The unified huntington\u2019s disease rating scale for advanced patients: validation and follow-up study","volume":"28","author":"Youssov","year":"2013","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib129","first-page":"187","article-title":"Rating scales for cognition in Huntington\u2019s disease: critique and recommendations","volume":"33","author":"Mestre","year":"2018","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib130","first-page":"149","article-title":"A\u00a0randomized feasibility study of a 12-week community-based exercise program for people with Huntington\u2019s disease","volume":"37","author":"Busse","year":"2013","journal-title":"J\u00a0NeurolPhysTher"},{"key":"10.1016\/j.ncl.2019.12.001_bib131","article-title":"Effects of a one year intensive multidisciplinary rehabilitation program for patients with Huntington\u2019s Disease: a prospective intervention study","volume":"5","author":"Piira","year":"2013","journal-title":"PLoSCurr"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib132","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/2013.jamaneurol.382","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease","volume":"70","year":"2013","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.001_bib133","first-page":"1223","article-title":"The relationship between CAG repeat length and clinical progression in Huntington\u2019s disease","volume":"23","author":"Ravina","year":"2008","journal-title":"MovDisord"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.001_bib134","first-page":"1466","article-title":"Rating scales for behavioral symptoms in Huntington\u2019s disease: critique and recommendations","volume":"31","author":"Mestre","year":"2016","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib135","first-page":"399","article-title":"Discriminant analysis of beck depression inventory and hamilton rating scale for depression in Huntington\u2019s disease","volume":"23","author":"Rickards","year":"2011","journal-title":"J\u00a0NeuropsychiatryClinNeurosci"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib136","first-page":"411","article-title":"Factor analysis of behavioural symptoms in Huntington\u2019s disease","volume":"82","author":"Rickards","year":"2011","journal-title":"J\u00a0NeurolNeurosurgPsychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib137","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000343210","article-title":"Course of irritability, depression and apathy in Huntington\u2019sdisease in relation to motor symptoms during a two-year follow-up period","volume":"13","author":"van Duijn","year":"2013","journal-title":"Neurodegener Dis"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib138","first-page":"527","article-title":"Assessment scales for patients with advanced Huntington\u2019s disease: comparison of the UHDRS and UHDRS-FAP","volume":"5","author":"Winder","year":"2018","journal-title":"MovDisordClinPract"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib139","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/ene.13889","article-title":"Longitudinal assessment of the Unified Huntington\u2019s Disease Rating Scale (UHDRS) and UHDRS\u2013For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington\u2019s disease","volume":"26","author":"Winder","year":"2019","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib140","first-page":"401","article-title":"The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington\u2019s disease","volume":"25","author":"Videnovic","year":"2010","journal-title":"MovDisord"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib141","first-page":"1744","article-title":"Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington\u2019s disease","volume":"28","author":"Gluhm","year":"2013","journal-title":"MovDisord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib142","first-page":"33","article-title":"Validity of the montreal cognitive assessment in the detection of cognitive dysfunction in Huntington\u2019s Disease","volume":"20","author":"Bezdicek","year":"2013","journal-title":"ApplNeuropsycholAdult"},{"key":"10.1016\/j.ncl.2019.12.001_bib143","unstructured":"Abnormal Involuntary Movement Scale (117-AIMS). In: Guy W, editor. ECDEU assessment manual for psychopharmacology: revised.; Rockville (MD): 1976."},{"issue":"3","key":"10.1016\/j.ncl.2019.12.001_bib144","article-title":"Revisiting the abnormal involuntary movement scale","volume":"79","author":"Kane","year":"2018","journal-title":"J\u00a0ClinPsychiatry"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib145","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1176\/ps.39.11.1172","article-title":"How to examine patients using the abnormal involuntary movement scale","volume":"39","author":"Munetz","year":"1988","journal-title":"Psychiatr Serv"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.001_bib146","first-page":"353","article-title":"Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale","volume":"173","author":"Lane","year":"1985","journal-title":"J\u00a0NervMent Dis"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib147","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2215-0366(17)30236-5","article-title":"Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"4","author":"Anderson","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib148","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14737175.2017.1386556","article-title":"Valbenazine for the treatment of tardive dyskinesia","volume":"17","author":"M\u00fcller","year":"2017","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib149","first-page":"1203","article-title":"Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference","volume":"34","author":"Stacy","year":"2019","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A\u00a0rating scale for tardive dyskinesia","volume":"64","author":"Simpson","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.001_bib151","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/npp.2011.55","article-title":"Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-na\u00efve patients","volume":"36","author":"Woerner","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.ncl.2019.12.001_bib152","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the extrapyramidal symptom rating scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"10.1016\/j.ncl.2019.12.001_bib153","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2005.03.008","article-title":"Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia","volume":"77","author":"Gharabawi","year":"2005","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib154","first-page":"1","article-title":"Unified Wilson\u2019s Disease Rating Scale - a proposal for the neurological scoring of Wilson\u2019s disease patients","volume":"41","author":"Cz\u0142onkowska","year":"2007","journal-title":"NeurolNeurochir Pol"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12883-017-0921-3","article-title":"Comparative assessment of clinical rating scales in Wilson\u2019s disease","volume":"17","author":"Volpert","year":"2017","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.001_bib156","first-page":"54","article-title":"Evaluation of the Unified Wilson\u2019s Disease Rating Scale (UWDRS) in German patients with treated Wilson\u2019s disease","volume":"23","author":"Leinweber","year":"2008","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib157","first-page":"509","article-title":"A\u00a0novel global assessment scale for Wilson\u2019s Disease (GAS for WD)","volume":"24","author":"Aggarwal","year":"2009","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib158","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology","volume":"145","author":"Trouillas","year":"1997","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.001_bib159","first-page":"190","article-title":"Inter-rater reliability of the international cooperative ataxia rating scale (ICARS)","volume":"19","author":"Storey","year":"2004","journal-title":"MovDisord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib160","first-page":"699","article-title":"Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients","volume":"21","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"MovDisord"},{"key":"10.1016\/j.ncl.2019.12.001_bib161","first-page":"135","article-title":"Validity and reliability of the international cooperative ataxia rating scale (ICARS) and the scale for the assessment and rating of ataxia (SARA) in multiple sclerosis patients with ataxia","volume":"18","author":"Salc\u0131","year":"2017","journal-title":"MultSclerRelatDisord"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib162","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: Development of a new clinical scale","volume":"66","author":"Schmitz-Hubsch","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib163","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dmcn.13291","article-title":"Reliability and discriminant validity of ataxia rating scales in early onset ataxia","volume":"59","author":"Brandsma","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.001_bib164","first-page":"1592","article-title":"Rating scale for psychogenic movement disorders: scale development and clinimetric testing","volume":"20","author":"Hinson","year":"2005","journal-title":"MovDisord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.001_bib165","first-page":"710","article-title":"A\u00a0simplified version of the psychogenic movement disorders rating scale: the simplified functional movement disorders rating scale (S-FMDRS)","volume":"4","author":"Nielsen","year":"2017","journal-title":"MovDisordClinPract"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.001_bib166","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bj.2018.06.003","article-title":"Wearable sensors for the monitoring of movement disorders","volume":"41","author":"Jalloul","year":"2018","journal-title":"Biomed J"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.001_bib167","doi-asserted-by":"crossref","first-page":"e0158852","DOI":"10.1371\/journal.pone.0158852","article-title":"A\u00a0validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson\u2019s Disease","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.001_bib168","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/14737175.2018.1530593","article-title":"Technology-based assessment of motor and nonmotor phenomena in Parkinson disease","volume":"18","author":"Merola","year":"2018","journal-title":"Expert Rev Neurother"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919301112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919301112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:19:25Z","timestamp":1760005165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861919301112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0733861919301112"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2019.12.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Rating Scales and Quantitative Assessments of Movement Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}